Ctx112, A Next-Generation Allogeneic Cd19 Car T-Cell, In Patients With R/R B-Cell Malignancies

CTX112, a next-generation allogeneic CD19 CAR T-cell, in patients with R/R B-cell malignancies

VJHemOnc – Video Journal of Hematology & HemOnc

CTX112, a next-generation allogeneic CD19 CAR-T product, for treating R/R B-cell malignancies

VJHemOnc – Video Journal of Hematology & HemOnc

Efficacy of bispecific CD19/CD22 CAR T-cells in B-cell malignancies

VJHemOnc – Video Journal of Hematology & HemOnc

CART19-BE-01 trial: next-generation CAR T-cell therapy for CD19+ R/R leukemia and lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc

CD19 CAR T-cells for adults

VJHemOnc – Video Journal of Hematology & HemOnc

Infusion of allogeneic anti-CD19 CAR T-cells is a promising approach after alloHSCT

EMJ

Update on CAR T-Cell Therapy | LRF Webinars

Lymphoma Research Foundation

CD19 Targeted CAR T-cell Therapy in LBCL

CD19 CAR T Cell Therapy for Pediatric ALL: The Seattle Children’s Experience

CAR T-Cell Therapy in High-Risk Non-Hodgkin Lymphoma

CD19 CAR T Cell Therapy in SLE (9.16.2022)

Current research on CD19 targeted CAR T-cells in relapsed B-cell ALL

VJHemOnc – Video Journal of Hematology & HemOnc

Key questions in the field of CD19 CAR T-cell therapy

VJHemOnc – Video Journal of Hematology & HemOnc

Clinical data for CD19-directed CAR T-cell products in ALL

VJHemOnc – Video Journal of Hematology & HemOnc

PBCAR0191, an allogeneic CAR T-cell therapy, in B-ALL

VJHemOnc – Video Journal of Hematology & HemOnc

Updates in CAR T Cell Therapies

National Cancer Institute

ADI-001: anti-CD20 CAR-engineered allogeneic γδ T cells in adults with B-cell malignancies

VJHemOnc – Video Journal of Hematology & HemOnc

CD19/CD20 dual STAR T-cell therapy for R/R B-ALL

VJHemOnc – Video Journal of Hematology & HemOnc

Chimeric Antigen Receptor T-Cell Therapy in ALL

Chimeric Antigen Receptor (CAR) Therapy